Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery. - Wikidata - wikimedia - TriplyDB

Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.

Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.

http://www.wikidata.org/entity/Q42534599

about

Eco-friendly (green) synthesis of magnetically active gold nanoclusters.Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.Microwave grafted, composite and coprocessed materials: drug delivery applications.Tannic acid-mediated surface functionalization of polymeric nanoparticles Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance.PEG/Dextran Double Layer Influences Fe Ion Release and Colloidal Stability of Iron Oxide Nanoparticles.Intracellular in situ labeling of TiO2 nanoparticles for fluorescence microscopy detection.Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity.Synthesis of Iron Oxide Nanoparticles Using Isobutanol

P2860

Q33596112-5CE879DC-280B-4F6A-B182-A5E49835DB9B Q38836010-45727366-2B2D-495A-A98D-26CF0792595A Q39010733-BC01600D-5ED1-4ED4-B0B9-3783A52E5FD3 Q41697936-B90972CB-6754-4AFE-BCB7-FAB9C09F17E0 Q47374159-D80C3615-ED58-46D6-AEBB-25A098E7C274 Q50660460-79F7106F-A816-40C0-8B54-164D1AADA047 Q51742009-A3F33EB0-1737-4F9A-B0F9-62002596EBFF Q52655030-E12ABA1D-1998-44B0-98F3-6DDBC04F4B79 Q55384208-CAFDE7D0-59E0-484C-86E3-251FE09A3521 Q59127625-D338FE25-E7D1-4EA3-8698-7A91897C4A95

P2860

Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.

http://www.wikidata.org/entity/Q42534599

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.

@en

Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.

@nl

type

label

Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.

@en

Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.

@nl

prefLabel

Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.

@en

Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.

@nl

P1433

Q42534599-C9061878-6280-4AFB-AE34-A33A666CFD58

P1476

Q42534599-DDD1A3F1-1221-4FED-82DC-A1A4EB7E0686

P2093

Q42534599-2F9DE76E-F1E3-43D0-A22D-149DE338D8CF

Q42534599-75A4CBDA-F507-48C9-A6CA-F50FE68BC833

Q42534599-7A3B11F5-913B-4AC5-8EF1-20064C5B24E3

Q42534599-B8006A8A-699A-4706-89BD-65BFB0A551CF

Q42534599-C441E762-5A8C-4B23-8456-602EFD4FE8E7

P2860

Q42534599-076A227F-E497-4526-A431-33B9950D22CD

Q42534599-106F9974-773F-49E8-9341-9C181D4C3CE5

Q42534599-1B7D96F5-2F03-4BCB-8436-89DB931AAC3D

Q42534599-1DBC2452-359A-4907-B028-61871ED0721F

Q42534599-2C2859EC-4824-4E3C-8B3A-85B8F8D9412B

Q42534599-33DC331E-7C4A-4689-B129-C185E14E58FD

Q42534599-3715248A-5F15-4B54-80A3-2EA2AEF76A2D

Q42534599-385E736C-89B3-4486-ACE6-E23080C53577

Q42534599-58579C38-A86B-421C-BEC8-629981F41435

Q42534599-60C521A6-3611-442A-9167-87D5287956BA

P304

Q42534599-034B21A1-B7EF-4ED0-9E1B-9C46DE73D4C1

P31

Q42534599-BD53EFA0-EE85-4933-85CB-A04E83989C3A

P356

Q42534599-F7B64B1C-0007-4E6C-81BD-00A19C7307AD

P478

Q42534599-6DD6B75A-8E44-4E32-97A0-7E0A99280714

P50

Q42534599-05791BDE-AA6A-4197-AF74-E7E09BC226D5

Q42534599-EAB4691D-4286-4D44-B9EB-29681BF1746B

P577

Q42534599-24201D40-8F6B-4A3C-9DD2-406F369581C8

P698

Q42534599-C6647C87-026E-46FA-859A-A7E57E23309C

P921

Q42534599-160B984E-23D5-42A4-B846-2E423BE2A320

Q42534599-B6E221EE-290D-4F8A-BE59-A4B780926DFD

P932

Q42534599-98A57DE6-5E58-49FD-A2CE-C62E9DC14892

P356

J.BIOMATERIALS.2016.06.007

P1433

P1476

Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.

@en

P2093

Alexander Wei

http://www.w3.org/2001/XMLSchema#string

David S Collins

http://www.w3.org/2001/XMLSchema#string

Jinho Park

http://www.w3.org/2001/XMLSchema#string

Mark A Castanares

http://www.w3.org/2001/XMLSchema#string

Naveen Reddy Kadasala

http://www.w3.org/2001/XMLSchema#string

P2860

Mussel-inspired surface chemistry for multifunctional coatings

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

Nanoparticle therapeutics: an emerging treatment modality for cancer

Nanocarriers as an emerging platform for cancer therapy

An overview of optical coherence tomography for ovarian tissue imaging and characterization.

Photoacoustic tomography: principles and advances.

Morphological and Biomechanical Differences in the Elastase and AngII apoE(-/-) Rodent Models of Abdominal Aortic Aneurysms.

Clinical applications of magnetic drug targeting.

Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology

EPR: Evidence and fallacy.

P304

285-295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOMATERIALS.2016.06.007

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Sara A Abouelmagd

P577

2016-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27310916

http://www.w3.org/2001/XMLSchema#string

P921

P932

4921297

http://www.w3.org/2001/XMLSchema#string